Hence, GRP75 may be a potential therapeutic target for ameliorating the neurotoxicity of apoE4 (Δ272–299), and our findings may uncover the molecular mechanisms by which GRP75 regulates the MAM calcium channel, contributing to the pathogenesis of neurodegenerative diseases. The gene discussed is APOE; the disease is neurodegenerative disease.